Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation.

Yu CL, Jin YJ, Burakoff SJ.

J Biol Chem. 2000 Jan 7;275(1):599-604.

4.

Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.

Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA.

Leuk Res. 1999 Apr;23(4):373-84.

PMID:
10229324
6.
7.

Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.

Chughtai N, Schimchowitsch S, Lebrun JJ, Ali S.

J Biol Chem. 2002 Aug 23;277(34):31107-14. Epub 2002 Jun 11.

8.

Identification of Shp-2 as a Stat5A phosphatase.

Chen Y, Wen R, Yang S, Schuman J, Zhang EE, Yi T, Feng GS, Wang D.

J Biol Chem. 2003 May 9;278(19):16520-7. Epub 2003 Mar 3.

10.
11.

SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells.

Lundin Brockdorff J, Woetmann A, Mustelin T, Kaltoft K, Zhang Q, Wasik MA, Röpke C, Ødum N.

Cytokine. 2002 Nov 24;20(4):141-7.

PMID:
12543077
12.

Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.

Yu WM, Hawley TS, Hawley RG, Qu CK.

Oncogene. 2003 Sep 4;22(38):5995-6004.

PMID:
12955078
13.

SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.

Ali S, Nouhi Z, Chughtai N, Ali S.

J Biol Chem. 2003 Dec 26;278(52):52021-31. Epub 2003 Oct 1.

14.

Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.

Adachi M, Ishino M, Torigoe T, Minami Y, Matozaki T, Miyazaki T, Taniguchi T, Hinoda Y, Imai K.

Oncogene. 1997 Apr 3;14(13):1629-33.

16.
17.

The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.

Akagi S, Ichikawa H, Okada T, Sarai A, Sugimoto T, Morimoto H, Kihara T, Yano A, Nakao K, Nagake Y, Wada J, Makino H.

J Am Soc Nephrol. 2004 Dec;15(12):3215-24.

19.

FLT3/ITD mutation signaling includes suppression of SHP-1.

Chen P, Levis M, Brown P, Kim KT, Allebach J, Small D.

J Biol Chem. 2005 Feb 18;280(7):5361-9. Epub 2004 Dec 1.

20.

Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.

Hackett RH, Wang YD, Sweitzer S, Feldman G, Wood WI, Larner AC.

J Biol Chem. 1997 Apr 25;272(17):11128-32.

Items per page

Supplemental Content

Write to the Help Desk